
    
      Patients receive intravenous DS-4152 by infusion twice weekly for 21 days, followed by 2
      weeks of rest; courses may repeat. Patients undergo weekly follow-up. A punch biopsy will be
      obtained from patients with Kaposi's sarcoma.
    
  